Drugs / Euvichol
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01707537 | Sep 2012 → Feb 2013 | — | EuBiologics Co.,Ltd | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT02164110 | May → Sep 2014 | — | EuBiologics Co.,Ltd | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02502331 Comparator | Mar → Jun 2016 | cholera | International Vaccine Institute | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Euvichol | “The 600L Euvichol® is safe and immunogenic in adults and children.” PMID 29895500 ↗ Jun 2018 |
| Modality | Vaccine | “Euvichol(Oral cholera vaccine)” NCT01707537 ↗ |
| Route | Oral | “To Determine the Safety and Immunogenicity of an Oral(Whole Cell) Euvichol Cholera Vaccine” NCT01707537 ↗ |